Faculty Introductions and Ethics and Academic Integrity Seminar
Wednesday, September 26, 2018
4:00 PM-5:30 PM
Faculty Introductions and Ethics and Scientific Integrity Seminar
Sri Balasubramanian, PhD, Associate Professor, School of Biomedical Engineering, Science and Health Systems, Drexel University
John Domzalski, JD, MPH, FCPP, Adjunct Professor, School of Biomedical Engineering, Science and Health Systems, Drexel University
Andres Kriete, PhD, Associate Dean for Academic Affairs and Teaching Professor, School of Biomedical Engineering, Science and Health Systems, Drexel University
Catherine von Reyn, PhD, Assistant Professor, School of Biomedical Engineering, Science and Health Systems, Drexel University
Wan Shih, PhD, Professor, School of Biomedical Engineering, Science and Health Systems, Drexel University
Faculty members from the School of Biomedical Engineering, Science and Health Systems will provide a brief overview of their respective research areas, research projects, and teams, along with any opportunities that might be available in their respective labs or partner laboratories, regionally, nationally, and internationally.
Ethics and Scientific Integrity:
Faculty will discuss and review the definition and examples of ethics, plagiarism, and cheating. Drexel Policies and School of Biomedical Engineering, Science and Health Systems policies will also be explained. These policies affect all faculty, students, staff, and any Biomed community members. Dr. Andres Kriete, Associate Dean for Academic Affairs, and John Domzalski, Adjunct Professor, will lead this discussion.
Dr. Sri Balasubramanian's research is focused on developing novel biomedical engineering methods and advanced computational modeling tools to address the burden of debilitating pediatric skeletal deformities, traumatic injuries, and orthopedic conditions.
John Domzalski has held a range of executive and senior leadership positions in public health and was the Health Commissioner for the City of Philadelphia from February, 2002 until his retirement from government service in July, 2005. He received his Juris Doctor degree from Temple University School of Law and his Master of Public Health degree from the University of Pittsburgh Graduate School of Public Health. Since July, 2005, he has worked in Southeast Texas providing hurricane disaster relief lectured to Foreign Service Nationals from Africa, East Asia, Europe, and the Near East on public health topics, and served as a panelist for the Public Broadcast Service global health series, Rx for Survival. He has taught in the School of Biomedical Engineering, Science and Health Systems for many years and won awards for his course on Biomedical Ethics and Law.
Dr. Andres Kriete's research focuses on the systems biology of aging, taking an integrative view of a biological process that disturbs a broad range of cellular and physiological functions in a complex and global fashion. He and his colleagues explore concepts from engineering (complex systems, robustness, control theory) to decipher the mechanisms of aging at the intersection of experimental, computational, and theoretical biology.
Dr. Catherine von Reyn's research uses diverse, cutting edge techniques, including cell type-specific genetic engineering, whole-cell patch clamp in behaving animals, modeling, and detailed behavioral analysis to identify and characterize sensorimotor circuits. She applies these techniques to engineer de novo synaptic connections in sensorimotor circuits, with the long-term goal of developing genetic strategies for re-engineering circuits in neurodegenerative and neurophysiological disorders.
Dr. Wan Shih's goal in translational biomedical research has been to combine her physical science and engineering background with medicine to create revolutionary biomedical devices to fulfill unmet needs in medicine. Since 2000, she has amply demonstrated her ability to create original, groundbreaking biomedical technologies, such as the groundbreaking piezoelectric finger (PEF) breast cancer detector that detects breast cancers undetectable by mammography, an intraoperative breast cancer margin assessment tool, and the revolutionary piezoelectric plate sensor (PEPS) molecular tests.